Phosphate

There are 124 papers on phosphate in aging research: 20 trials and 67 observational studies in people, 19 in animals, 17 reviews. The newest story, Oct 28, 2026: “Model predicted cardiovascular risk in peritoneal dialysis patients”.

Biomarker

124 papers study it1,128 more mention it39 findings

MeSH

54 new papers in 30 daysSee all 1,252 papers on phosphate

“Sarcopenia was associated with higher concentrations of phosphate, lipoprotein A”
Biomarkers Profile of People With Sarcopenia: A Cross-sectional Analysis From UK BiobankJournal of the American Medical Directors Association2020doi:10.1016/j.jamda.2020.05.005
  • Human trial20
  • Humans67
  • Animals19

Interventions

7

Phosphate binders

downin humans1

1 study
  1. Phosphate binders decrease phosphate in pre-dialysis CKD patients with hyperphosphataemia.

    “The use of phosphate binders in pre-dialysis CKD significantly reduced serum phosphate”

    Human trialin pre-dialysis CKD patients with hyperphosphataemia3 monthsn = 72

    Effect of Dietary Phosphate Restriction in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphataemia in Southern Nigeria

    West African journal of medicine

More on Phosphate binders

Dietary phosphate restriction

no changein humans1

1 study
  1. Dietary phosphate restriction showed no clear effect on phosphate in humans (pre-dialysis CKD patients with hyperphosphataemia receiving phosphate binders).

    “additional dietary phosphate restriction had no significant effect on serum phosphate lowering”

    Human trialpre-dialysis CKD patients with hyperphosphataemia receiving phosphate binders3 monthsn = 72

    Effect of Dietary Phosphate Restriction in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphataemia in Southern Nigeria

    West African journal of medicine

More on Dietary phosphate restriction

Sulforaphane

upin humans1

1 study
  1. Sulforaphane improves phosphate in humans (non-dialysis chronic kidney disease) (p = 0.02).

    “we observed an improvement in the levels of phosphate (p = 0.02), glucose (p = 0.05) and triglycerides (p = 0.02) also in this group.”

    Human trialnon-dialysis chronic kidney disease400 μg/day1 month

    Sulforaphane upregulates the mRNA expression of NRF2 and NQO1 in non-dialysis patients with chronic kidney disease

    Free radical biology & medicine

More on Sulforaphane

Low-phosphate diet

downin mice1

1 study
  1. Low-phosphate diet decreases phosphate in older mice (19.09 ± 0.75 mg/dL old with low phosphate diet vs 23.23 ± 0.81 mg/dL old).

    “(17.24 ± 0.77 mg/dL young; 23.23 ± 0.81 mg/dL old; 19.09 ± 0.75 mg/dL old with low phosphate diet)”

    Animalsin older mice3 months

    Aging-related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle

    Journal of cachexia, sarcopenia and muscle

More on Low-phosphate diet

Caloric restriction

downin reviews1

1 study
  1. Caloric restriction decreases phosphate.

    “caloric restriction decreases plasma P concentrations”

    Review

    Caloric Intake in Renal Patients: Repercussions on Mineral Metabolism

    Nutrients

More on Caloric restriction

Testosterone

downin humans1

1 study
  1. Testosterone decreases phosphate in humans (compared with placebo gel).

    “The plasma levels of calprotectin and phosphate were significantly reduced in the group receiving testosterone therapy (gel) compared to the placebo group (p < 0.05).”

    Human trialcompared with placebo gelgel5-10 g gel/50-100 mg testosterone6 monthsmalesn = 48

    Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial

    Journal of endocrinological investigation

More on Testosterone

Growth hormone-releasing hormone

upin humans1

1 study
  1. Growth hormone-releasing hormone increases phosphate in humans (Healthy nonobese old men).

    “Phosphate levels increased (P less than 0.05) during GHRH treatment.”

    Human trialHealthy nonobese old men14 daysmalesn = 10

    Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men

    The Journal of clinical endocrinology and metabolism

More on Growth hormone-releasing hormone

Effects

6

Mortality

no changein humans1downin humans1

2 studies
  1. Phosphate was not clearly linked with mortality in humans (estimated glomerular filtration rate ≥60 mL/min/1.73 m2) (aHR 1.01 (95% CI, 0.92-1.12)).

    “no association was observed in those with estimated glomerular filtration rate ≥60 mL/min/1.73 m2 (aHR 1.01 [95% CI, 0.92-1.12]”

    Humansestimated glomerular filtration rate ≥60 mL/min/1.73 m2

    Association between serum phosphate levels within the normal range and all-cause mortality among US adults

    Journal of the Endocrine Society

  2. Phosphate decreases mortality in hemodialysis patients.

    “reduced serum phosphate levels have been linked to a lower mortality risk”

    Reviewin hemodialysis patientsserum

    The benefit of reduced serum phosphate levels depends on patient characteristics: a nationwide cohort study

    Clinical kidney journal

Handgrip strength

downin humans2

2 studies
  1. Phosphate is linked with worse handgrip strength in humans.

    “the combination of high hsCRP and elevated phosphate levels had a more pronounced impact on reducing handgrip strength than either factor alone”

    Humansmalesn = 2,006

    Sex-dependent interplay of phosphate and inflammation on muscle strength irrespective of muscle mass in middle-aged and older adults

    Experimental gerontology

  2. Phosphate is linked with lower handgrip strength in humans (advanced chronic kidney disease) (standardized β = -0.168, p = 0.022).

    “Multivariable analysis revealed that serum Pi was significantly associated with handgrip strength (standardized β = -0.168; p = 0.022)”

    Humansadvanced chronic kidney disease

    Association of Serum Phosphate with Low Handgrip Strength in Patients with Advanced Chronic Kidney Disease

    Nutrients

Rehospitalization

no changein humans1

1 study
  1. Phosphate was not clearly linked with rehospitalization in humans after correction for confounding variables.

    “After correction for confounding variables, phosphate was not an independent predictor of these outcomes”

    Humansafter correction for confounding variables

    ELECTROHEALTH study: prevalence and prognostic significance of mild hypophosphatemia in older adults

    Aging clinical and experimental research

C-reactive protein

no changein humans1

1 study
  1. Phosphate was not clearly linked with C-reactive protein in humans.

    “In women, circulatory phosphate was not associated with inflammation (hsCRP levels)”

    Humansfemalesn = 2,006

    Sex-dependent interplay of phosphate and inflammation on muscle strength irrespective of muscle mass in middle-aged and older adults

    Experimental gerontology

More on C-reactive protein

Bone fracture

no changein humans1HR 1.09

1 study
  1. Phosphate was not clearly linked with bone fracture in humans (HR 1.09, 95% CI 0.83-1.44).

    “No such association was observed for women (HR 1.09; 95% CI, 0.83-1.44).”

    Humansfemales

    Association of Serum Phosphate, Calcium and Alkaline Phosphatase With Risk of Incident Fractures in Healthy Older Adults

    The Journal of clinical endocrinology and metabolism

More on Bone fracture

Lean body mass

no changein humans1

1 study
  1. Phosphate was not clearly linked with lean body mass in humans.

    “Phosphate was inversely associated with fat%, but not with lean mass, in both sexes.”

    Humansn = 9,202

    Serum Phosphate, BMI, and Body Composition of Middle-Aged and Older Adults: A Cross-Sectional Association Analysis and Bidirectional Mendelian Randomization Study

    The Journal of nutrition

Upstream

1

Body mass index

downin humans1

1 study
  1. Body mass index is linked with lower phosphate in humans (β: -0.01; 95% CI: -0.02, 0.00).

    “MR analyses suggested a causal effect of BMI on serum phosphate (β: -0.01; 95% CI: -0.02, 0.00) but not vice versa.”

    Humansn = 7,983

    Serum Phosphate, BMI, and Body Composition of Middle-Aged and Older Adults: A Cross-Sectional Association Analysis and Bidirectional Mendelian Randomization Study

    The Journal of nutrition

Associations

18

Mortality

upin humans3no changein humans1HR 1.58

3 studies
  1. Phosphate is linked with a higher risk of mortality in humans among individual with CKD (aHR 1.13 (95% CI, 1.02-1.25)).

    “among individual with CKD, higher-normal serum phosphate was significantly associated with increased all-cause mortality (aHR 1.13 [95% CI, 1.02-1.25])”

    Humansamong individual with CKD

    Association between serum phosphate levels within the normal range and all-cause mortality among US adults

    Journal of the Endocrine Society

  2. Phosphate is associated with mortality in humans (overall population) (aHR 1.06 (95% CI, 0.98-1.13)).

    “Compared to the lower-normal group, the higher-normal group showed no significant increase in all-cause mortality risk in the overall population (aHR 1.06 [95% CI, 0.98-1.13]).”

    Humansoverall populationn = 15,848

    Association between serum phosphate levels within the normal range and all-cause mortality among US adults

    Journal of the Endocrine Society

  3. Phosphate is linked with a higher risk of mortality in humans (prior ACVD) (HR 1.58, 95% CI 1.38-1.81).

    “The hazard ratios (95% confidence interval) for phosphate ≥7.0 mg/dL compared with 3.5-<3.9 mg/dL were 1.58 (1.38-1.81) in those with prior ACVD”

    Humansprior ACVDserum≥7.0 mg/dL vs 3.5-<3.9 mg/dL9 yearsn = 78,256

    The benefit of reduced serum phosphate levels depends on patient characteristics: a nationwide cohort study

    Clinical kidney journal

  4. Phosphate is linked with a higher risk of mortality in humans (advanced non-dialysis CKD) (aHR 1.35, 95% CI 1.00-1.84).

    “phosphate (aHR 1.35, 95% CI 1.00-1.84, P = .05), but not calcium (aHR 1.11, 95% CI 0.57-2.17, P = .76), were associated with all-cause mortality.”

    Humansadvanced non-dialysis CKDn = 1,294

    Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Sarcopenia

downin humans2upin humans1OR 0.677

3 studies
  1. Phosphate is linked with a lower risk of sarcopenia in humans (maintenance hemodialysis) (OR 0.677;CI95% 0.493-0.93).

    “Logistic regression analysis found higher phosphate serum level and high physical activity protective of sarcopenia (OR 0.677;CI95% 0.493-0.93 and OR 0.313;CI95% 0.130-0.755 respectively).”

    Humansmaintenance hemodialysisn = 96

    Factors Associated with Sarcopenia in Maintenance Hemodialysis Patients: A Cross-Sectional Study

    Acta medica Indonesiana

  2. Sarcopenia is associated with phosphate in humans (maintenance dialysis) (p = 0.04).

    “Sarcopenia was associated with low serum albumin (p = 0.02) and low serum phosphate level (p = 0.04).”

    Humansmaintenance dialysisn = 39

    Prevalence and Factors Associated with Sarcopenia in Patients on Maintenance Dialysis in Australia-A Single Centre, Cross-Sectional Study

    Nutrients

  3. Phosphate is associated with sarcopenia in humans (EWGSOP2 definition).

    “Sarcopenia was associated with higher concentrations of phosphate, lipoprotein A”

    HumansEWGSOP2 definitionwomens

    Biomarkers Profile of People With Sarcopenia: A Cross-sectional Analysis From UK Biobank

    Journal of the American Medical Directors Association

More on Sarcopenia

Frailty

upin humans1

1 study
  1. Phosphate is associated with frailty in humans (CKD stage 5D receiving maintenance hemodialysis) (p = 0.04).

    “Phosphate levels were significantly associated with frailty in the prefrail-vs-frail comparison (p = 0.04)”

    HumansCKD stage 5D receiving maintenance hemodialysisn = 50

    Frailty Syndrome in Non-geriatric Dialysis Patients in Georgia: Prevalence and Clinical Correlates in a Cross-Sectional Study

    Cureus

Lumbar spine bone mineral density

downin humans1

1 study
  1. Phosphate is associated with lumbar spine bone mineral density in humans (Postpartum women).

    “There was a significant inverse association between serum phosphate levels and BMD at the lumbar spine.”

    HumansPostpartum womenLumbar spinefemales

    Serum 25-hydroxy vitamin D, calcium, phosphate, and magnesium levels in association with bone mineral density at the hip and lumbar spine in African breastfeeding women: a longitudinal evaluation

    BMC nutrition

Hepatic encephalopathy

upin humans1

1 study
  1. Phosphate is linked with a higher risk of hepatic encephalopathy in humans (retrospective study in cirrhosis patients).

    “serum Pi is an independent risk factor for cirrhosis progression to HE”

    Humansretrospective study in cirrhosis patientsn = 185

    Phosphate binders suppress glutaminase activity for treatment of cirrhosis and hepatic encephalopathy murine models

    Biochemical pharmacology

More on Hepatic encephalopathy

Systolic blood pressure

downin humans1

1 study
  1. Phosphate is associated with systolic blood pressure in humans (p<0.05).

    “In the fully adjusted models, serum Ca/P and calcium were positively associated with mean SBP and DBP while serum phosphate showed an inverse association (all p<0.05).”

    Humansn = 4,621

    Associations Between Calcium-Phosphate Ratio and Blood Pressure in Non-CKD Populations

    AHA Scientific Sessions 2025 abstract

More on Systolic blood pressure

Age-related macular degeneration

upin humans1

1 study
  1. Phosphate is linked with a higher risk of age-related macular degeneration in humans (health screening examination).

    “Higher serum inorganic phosphate levels (p = 0.002) and lower total serum ALB levels (p = 0.005) were significant risk factors for advanced AMD.”

    Humanshealth screening examinationretinan = 73,574

    A Comprehensive Health Screening Program Reveals the Prevalence of and Risk Factors for Age-Related Macular Degeneration: A Cross-Sectional Analysis

    Biomedicines

More on Age-related macular degeneration

C-reactive protein

upin humans1

1 study
  1. Phosphate is associated with C-reactive protein in humans.

    “while in men, higher phosphate levels were significantly associated with higher hsCRP levels”

    Humansmalesn = 2,006

    Sex-dependent interplay of phosphate and inflammation on muscle strength irrespective of muscle mass in middle-aged and older adults

    Experimental gerontology

More on C-reactive protein

Handgrip strength

downin humans1

1 study
  1. Phosphate is associated with handgrip strength in both men and women.

    “higher phosphate levels were significantly associated with weaker handgrip strength but not with reduced muscle mass in both men and women”

    Humansin both men and womenn = 2,006

    Sex-dependent interplay of phosphate and inflammation on muscle strength irrespective of muscle mass in middle-aged and older adults

    Experimental gerontology

Bone fracture

upin humans1HR 1.78

1 study
  1. Phosphate is linked with a higher risk of bone fracture in humans (top decile (D10)) (HR 1.78, 95% CI 1.25-2.54).

    “men in the top decile (D10) of phosphate had a 78% higher risk of incident fracture (HR 1.78; 95% CI, 1.25-2.54).”

    Humanstop decile (D10)males

    Association of Serum Phosphate, Calcium and Alkaline Phosphatase With Risk of Incident Fractures in Healthy Older Adults

    The Journal of clinical endocrinology and metabolism

More on Bone fracture

All 18

Funding

23 grants since 2018

National Institute of Diabetes and Digestive and Kidney Diseases$6.3MUS Department of Veterans AffairsJapan Society for the Promotion of Science¥47.3M

Latest

Dec 2025: 14Jan 2026: 35Feb 2026: 30Mar 2026: 33Apr 2026: 11May 2026: 13Jun 2026: 21Jul 2026: 18Aug 2026: 19Sep 2026: 21Oct 2026: 41Nov 2026: 19275 papers in 12 months
Clinical and Translational Medicine

Model predicted cardiovascular risk in peritoneal dialysis patients

The model scored 0.822 in external validation, compared with 0.784 in training and 0.781 in internal testing, on a measure of its ability to distinguish disease.The model scored 0.822 in external validation, compared with 0.784 in training and 0.781 in internal testing, on a measure of its ability to distinguish disease.

Cohort · 102 peopleCardiovascular disease
Journal of Lipid Research

Fats in human lenses varied by region and cataract status

An observational comparison of human lenses with and without cataracts mapped lipid distributions and found more extensive chemical modification and breakdown in…An observational comparison of human lenses with and without cataracts mapped lipid distributions and found more extensive chemical modification and breakdown in cataractous lenses.

Case-control studyEye
Communications Biology

Drugs and diet reduced ligament mineral deposits in zebrafish

In zebrafish deficient in a collagen gene, drugs and calorie restriction reduced abnormal mineral buildup in ligaments between spinal bones.In zebrafish deficient in a collagen gene, drugs and calorie restriction reduced abnormal mineral buildup in ligaments between spinal bones.

Fish studyInterventions
bioRxiv

Gene deletion eased osteoarthritis but hindered bone growth in mice

Cartilage-specific gene deletion reduced obesity-associated disease in male and female mice but disrupted bone growth when done early after birth.Cartilage-specific gene deletion reduced obesity-associated disease in male and female mice but disrupted bone growth when done early after birth.

Preprint: mouse studyBones and joints

See all 1,252 papers on phosphate